Relationship between treatment delay and final infarct size in STEMI patients treated with abciximab and primary PCI
BMC Cardiovascular Disorders, 02/24/2012Todt T et al.
In patients with ST–Elevation Myocardial Infarction (STEMI) treated with primary percutaneous coronary intervention (PCI) authors found a weak correlation between health care delay time and infarct size. Other factors like anterior infarction, a patent artery pre–PCI and effects of reperfusion injury may have had greater influence on infarct size than time–to–treatment per se.
Between February 2006 and September 2007, 89 STEMI patients treated with primary PCI were studied with contrast enhanced magnetic resonance imaging (ceMRI) 4 to 8 weeks after the infarction.
Spearman correlation was computed for health care delay time (defined as time from FMC to PCI) and myocardial injury.
Multiple linear regression was used to determine covariates independently associated with infarct size.
An occluded artery (Thrombolysis In Myocardial Infarction, TIMI flow 0–1 at initial angiogram) was seen in 56 patients (63%).
The median FMC–to–patent artery was 89 minutes.
There was a weak correlation between time from FMC–to–patent IRA and infarct size, r = 0.27, p = 0.01.
In multiple regression analyses, LAD as the IRA, smoking and an occluded vessel at the first angiogram, but not delay time, correlated with infarct size.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.